Filters
Pharmacotherapy of heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction is common and treatment is difficult. Disease modifying drugs in heart failure with reduced ejection fraction have not been effective in subjects with preserved ej...
Cardiac and Cardiovascular systems
- 2017 •
- Jost
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
EMPEROR-reduced - empagilflozin in patients with heart failure and low ejection fraction.
The results of the EMPEROR reduced study - empagliflozin in patients with heart failure and low ejection fraction.
Cardiac and Cardiovascular systems
- 2020 •
- Jost •
- Link
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Výsledek na webu
Heart failure with preserved ejection fraction
, prognosis and treatment in heart failure with preserved left ventricular ejection fraction. Prevalence of heart failure in Europe is increasing and at least 50% of patients with heartfailure have preserved left ventricular eje...
FA - Kardiovaskulární nemoci včetně kardiochirurgie
- 2008 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Heart failure with normal ejection fraction
Heart failure with normal ejection fraction; left ventricular diastolic dysfunction; tissue Doppler; natriuretic peptides...
FA - Kardiovaskulární nemoci včetně kardiochirurgie
- 2008 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Dapagliflozin in patients with heart failure with reduced ejection fraction
SGLT2 co-transporter inhibition with glifozins is one of new trends in the therapy of heart failure with reduced ejection fraction.
Cardiac and Cardiovascular systems
- 2021 •
- O •
- Link
Rok uplatnění
O - Ostatní výsledky
Výsledek na webu
Heart failure with reduced left ventricular ejection fraction
to the ejection fraction of the left ventricle into the group with reduced, mildly reduced, and preserved ejection fraction. The guidelines follow the recent evidence-based medicine ejection fractions...
Cardiac and Cardiovascular systems
- 2023 •
- Jost •
- Link
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Výsledek na webu
Novel approaches in the pharmacotherapy of heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction is in the population of subjects in heart failure with reduced ejection fraction have not been effective in subjects with preserved ejection fraction...
Cardiac and Cardiovascular systems
- 2020 •
- Jost •
- Link
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Výsledek na webu
Heart failure with preserved ejection fraction
heart failure, ejection fraction, diastolic dysfunction, arterial hypertension, left ventricular hypertrophy...
FA - Kardiovaskulární nemoci včetně kardiochirurgie
- 2007 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction occurs almost with the same frequency as heart failure with reduced ejection fraction. The diagnosis is based on echocardiography with evidence-based ejection...
FA - Kardiovaskulární nemoci včetně kardiochirurgie
- 2016 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
Relationship between ejection fraction and blood pressure and baroreflex sensitivity in children and adolescent after anthracycline therapy
The positive correlation between ejection fraction and blood pressure may be and indicator a link between the changes of blood pressure and anthracycline's cardiotoxicity. Baroreflex was not significantly influenced....
ED - Fyziologie
- 2006 •
- O
Rok uplatnění
O - Ostatní výsledky
- 1 - 10 out of 14 061